Same Indication

Ipilimumab vs Midazolam

Ipilimumab vs Midazolam: Overview

This comparison examines the pharmacological differences between Ipilimumab and Midazolam.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Midazolam — 1.5-2.5 hours.

Chemical Properties

Molecular Formula: Midazolam — C18H13ClFN3.

Molecular Weight: Midazolam — 325.7670 g/mol.

Type: Ipilimumab — Antibody; Midazolam — Small molecule.